Connect With Us
Subscribe Now
Log In
Home
News
Education
Health
Tech
STEM
Advanced Manufacturing & Logistics
Life Sciences
Ag INnovation
INPower
Videos
Big Wigs
Submit Big Wigs
Events
Innovate Southwest Indiana â Evansville
Innovate West Central Indiana – Terre Haute
Innovate East Central – Muncie
Innovate Northeast Indiana – Fort Wayne
Newsletters
Podcasts
On-Air
TV & Radio Listings
Content Studio
Sponsored Content
Contact
About IIB
Meet the Team
Contact Us
Advertise
Gift Cards
Flagship Stations
Gerry’s Message
Speaking Engagement Request
Search
GO
Connect With Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Rhenium/SCT
Recent news which mentions Rhenium/SCT
OncoBeta reports 12-Month Results from International Phase IV Study for Non-Melanoma Skin Cancer
August 13, 2025
Tags
Rhenium/188
EPIC/Skin
Clinical Study
From
PRLog
OncoBeta introduces Rhenium-SCT for non-melanoma skin cancer patients at Hospital Universitario 12 de Octubre
June 20, 2024
Tags
Bavaria
Non/invasive
Munich
From
PRLog
Focusing on Treatment Education in Austria this May for Skin Cancer Awareness Month
May 17, 2024
Tags
Medical
Skin Cancer Awareness Month
Beauty
From
PRLog
Focusing on Treatment Education this May for Skin Cancer Awareness Month in UK
May 17, 2024
Tags
Rhenium/SCT
Health
Non/melanoma skin cancer
From
PRLog
Latest study demonstrates high efficacy in curing invasive non-melanoma skin cancer
October 25, 2023
Tags
Queensland
Medical
Brisbane
From
PRLog
Fully recruited EPIC-Skin international study for the treatment of Non-Melanoma Skin Cancer
July 11, 2023
Tickers
EPIC
Tags
Business
Bavaria
Munich
From
PRLog
GenesisCare and OncoBeta announce partnership to provide innovative treatment for non-melanoma skin cancer
May 17, 2023
Tags
Rhenium/SCT
OncoBeta GmbH
Marketing
From
PRLog
South African skin cancer patients undergo first treatments with OncoBeta's Rhenium-SCT as part of the EPIC-Skin study
December 22, 2022
Tags
Clinical Study
Medical
EPIC/Skin
From
PRLog
London skin cancer patients undergo first treatments with OncoBeta's Rhenium-SCT as part of the EPIC-Skin study
September 27, 2022
Tags
London, Greater
England
Painless
From
PRLog
German skin cancer patients join the EPIC-Skin study
July 28, 2022
Tags
Rhenium/188
EPIC/Skin
Medical
From
PRLog
Perth skin cancer patients undergo first treatments with OncoBeta's Rhenium-SCT as part of the EPIC-Skin study
June 15, 2022
Tags
Medical
Perth
EPIC/Skin
From
PRLog
Sydney skin cancer patients join the EPIC-Skin study as they undergo first treatments with OncoBeta's Rhenium-SCT
April 13, 2022
Tags
Non/invasive
Munich
NMSC therapy
From
PRLog
Austrian skin cancer patients take part in EPIC-Skin clinical study
March 15, 2022
Tags
OncoBeta
Austria
Investment
From
PRLog
EPIC-Skin study welcomes world-first skin cancer patients treated with OncoBeta's Rhenium-SCT
March 10, 2022
Tags
Medical
EPIC/Skin
Rhenium/188
From
PRLog
First Patients Registered Into OncoBeta's International Registry For Non-Melanoma Skin Cancer Treatments
February 14, 2022
Tags
Rhenium/188
NMSC Registry
International Registry
From
PRLog
OncoBeta receives ethics approval for EPIC-Skin study to evaluate Rhenium-SCT in Australia
December 21, 2021
Tags
Skin Cancer Therapy
Beauty
Research
From
PRLog
OncoBeta launches International Registry for Non-Melanoma Skin Cancer
November 24, 2021
Tags
New South Wales
Bavaria
Munich
From
PRLog
South African non-melanoma skin cancer patients now have greater access in the area of Johannesburg to innovative non-invasive treatment Rhenium-SCT®
November 16, 2021
Tags
Medical
Rhenium/188
Skin Cancer Therapy
From
PRLog
Australian Nuclear Science and Technology Organization (ANSTO), the new production partner of OncoBeta® GmbH in Australia
July 13, 2021
Tags
Painless
New South Wales
Technology
From
PRLog
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.